#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Infantile apnoea Oesophageal squamous cell carcinoma stage III Homocystinuria Mantle cell lymphoma recurrent Blood iron increased Leukocyte adhesion deficiency type I Marginal zone lymphoma Systemic lupus erythematosus Soft tissue sarcoma Bronchiolitis Myotonia Brain stem glioma Cytomegalovirus infection Cutaneous calcification General anaesthesia More trials…

    Learn about Rare Diseases

    Osteosarcoma Von Willebrand’s disease – Life with Disease Factor VIII deficiency – Life with Disease Hereditary motor and sensory neuropathy – Treatment Kearns-Sayre syndrome – Diagnostics Wiskott-Aldrich syndrome – Treatment Factor IX deficiency Andersen-Tawil syndrome – Trials in Disease Lymphangioma – Life with Disease Pelizaeus-Merzbacher disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Glucose Bi 690517 Lactulose PRILOCAINE HYDROCHLORIDE Mva-209-Fsp-B4 Tisagenlecleucel Vb10.16 Sugammadex Epirubicin Hydrochloride Sabestomig Rigosertib Sodium Spartalizumab Bay 3283142 Acp-017 Etrumadenant VTX2735 SODIUM IDROXIOLEIC ACID Namodenoson Lithium Sulphate, Anhydrous Dexamethasone Acetate Ph. Eur. More therapies…

    Learn about Your Condition

    Adenocarcinoma of colon Testis cancer Transferrin decreased Anaplastic thyroid cancer Peripheral ischaemia Cystic fibrosis Tympanic membrane perforation Coagulopathy Liver transplant rejection Myopia Metastases to rectum Brain neoplasm Hyperparathyroidism primary Breast cancer Cystic fibrosis lung More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Orszagos Onkologiai Intezet

Orszagos Onkologiai Intezet

Rath Gyorgy Utca 7-9, Kerulet, Budapest, 1122, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy and Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    • Dexamethasone
    • Dexamethasone Acetate
    Austria Czechia Denmark Finland France Germany +8

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    • Dexamethasone
    • Dexamethasone Acetate
    Czechia Estonia France Germany Greece Hungary +9

  • Study on the Effects of Ficlatuzumab and Cetuximab for Adults with Recurrent or Metastatic HPV-Negative Head and Neck Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Ficlatuzumab
    • Cetuximab
    Belgium Bulgaria Czechia France Germany Hungary +5

  • Study on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    • Non-small cell lung cancer
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • 2-Amino-9-((2R,4R,5R)-4-Hydroxy-5-(Hydroxymethyl) Tetrahydrofuran-2-Yl)-1,4,5,9-Tetrahydro-6H-Purine-6-Thione
    • Cemiplimab
    Bulgaria Hungary Poland Romania

  • Study on Lutetium (177Lu) Vipivotide Tetraxetan to Delay Recurrence in Adult Men with PSMA-Positive Oligometastatic Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    • Prostate cancer metastatic
    Investigated Drugs:
    • Piflufolastat (18F)
    • Gozetotide
    • Lutetium (177Lu) Vipivotide Tetraxetan
    Austria Belgium Czechia France Germany Greece +5

  • Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Favezelimab
    • Olaparib
    • Lenvatinib
    Austria Belgium Czechia Denmark Estonia Finland +15

  • Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Goserelin
    • Leuprorelin
    • Triptorelin
    Austria Belgium Bulgaria Czechia France Germany +8

  • Study on the Safety and Effectiveness of VB10.16 and Pembrolizumab for Patients with HPV16-Positive Head and Neck Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Vb10.16
    • Pembrolizumab
    Czechia France Germany Hungary Norway Poland +1

  • Study on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Sodium Chloride
    Bulgaria Croatia Hungary Poland Romania

  • Study of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Central nervous system lymphoma
    Investigated Drugs:
    • Temozolomide
    • Rituximab
    Austria Belgium Czechia France Germany Hungary +3
Previous Page
1 … 4 5 6 7 8 … 17
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!